Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies

Breast Cancers Clinical Trial

Official title: 3D Breast Ultrasound In Predicting Response to Breast Cancer Therapies

Status Completed

Clinical Trial Summary

The purpose of this study is to determine how well changes can be determined in malignant masses from ultrasound scans.

Clinical Trial Description

To evaluate the proportions of correct diagnosis of response to breast Cancer therapies for localized breast cancer by ultrasound. To develop a model based on patient characteristics, physical exam, and radiologic studies which will predict the possibility that a patient has had a complete pathological response to chemotherapy neoadjuvant therapy. ;

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

• Breast Cancers
• Breast Neoplasms

• NCT number: NCT00721903
• Study type: Interventional
• Source: University of Michigan
• Status: Completed
• Phase: N/A
• Start date: March 2000
• Completion date: September 2014